Skip to main content
Signal8

Cohen Yuval

SEC insider (Form 3/4/5 filer). CIK 0001626003. Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP). 9 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in NORWOOD, MA.

Companies Cohen Yuval has filed insider reports for

  • Corbus Pharmaceuticals Holdings, Inc. (CRBP): Director, Officer, Chief Executive Officer
Cohen Yuval profile photo

Cohen Yuval

CIK: 0001626003

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (55.6%)

Position reduction

Option Exercises (M)2 (22.2%)

Derivative conversions

Awards (A)2 (22.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Corbus Pharmaceuticals Holdings, Inc. logo
CRBP

Corbus Pharmaceuticals Holdings, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Aug 7, 2026
    Sale
    Direct
    17K shares at avg. $10.08$171K
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Feb 13, 2026
    Sale
    Direct
    13.9K shares at avg. $7.78$108K
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Jan 14, 2026
    Award
    Direct
    50K shares-
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Oct 27, 2025
    Exercise
    Direct
    9K shares at avg. $4.26$38K
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Oct 27, 2025
    Sale
    Direct
    9K shares at avg. $17.14$154K
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Oct 24, 2025
    Sale
    Direct
    18.7K shares at avg. $17.01$317K
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Oct 24, 2025
    Exercise
    Direct
    18.7K shares at avg. $4.26$79K
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Feb 14, 2025
    Sale
    Direct
    7.1K shares at avg. $8.76$62K
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Jan 31, 2025
    Award
    Direct
    68.1K shares-

1-9 of 9